Curtanapharma
Austin, US · 1 known investors
Find your way into Curtanapharma
Curtana Pharmaceuticals develops small molecule drugs targeting cancer stem cells in brain tumors, specifically gliomas and related CNS malignancies. The company focuses on OLIG2 inhibition to overcome treatment resistance and recurrence in pediatric and adult brain cancers.
Founders & leadership
GS
Gregory SteinChief Executive Officer, Co-Founder, Chairman
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Curtanapharma do?
- Curtana Pharmaceuticals develops small molecule drugs targeting cancer stem cells in brain tumors, specifically gliomas and related CNS malignancies. The company focuses on OLIG2 inhibition to overcome treatment resistance and recurrence in pediatric and adult brain cancers.
- Who founded Curtanapharma?
- Curtanapharma was founded by Gregory Stein.
- Who are Curtanapharma's investors?
- Curtanapharma's investors include Thynk Capital.
- Where is Curtanapharma headquartered?
- Curtanapharma is headquartered in Austin, US.